| Document Date: 2013-11-16 23:40:47
Open Document File Size: 194,81 KBShare Result on Facebook
City Cambridge / Toronto / / Company RIC / CellAegis Devices Inc. / / Continent Europe / / Country Germany / United States / Canada / United Kingdom / Denmark / / Event FDA Phase / / Facility University Health Network / Aarhus University / Princess Margaret Hospital / Essen University / / / IndustryTerm treatment / medical devices / acute care applications / diverse applications / manufacturing / healthcare professional / control / / MedicalCondition larger injury / chest pain / elevation myocardial infarction / acute kidney injury / stroke / myocardial infarction / heart failure / heart attack / myocardial infarctions / renal cell carcinoma / renal injury / myocardial injury / acute myocardial infarction / / MedicalTreatment coronary artery bypass surgery / cardiac surgery / angioplasty / ischemic preconditioning / / Organization European Union / / Person Ganske / / / Position CEO / physician / Major / Princess / / Product autoRIC / autoRIC Device / Remote Ischemic Conditioning / / ProvinceOrState Connecticut / Ontario / / Technology transplantation / / URL www.cellaegis.com / http /
SocialTag |
CellAegis Devices Inc. 139 Mulock Ave., 1st Floor Toronto, Ontario M6N 1G9 Main Office: [removed]Fax: [removed]www.cellaegis.com